107 related articles for article (PubMed ID: 20446263)
1. [Hereditary complement C5 deficiency: study of 3 Tunisian adult cases and literature review].
Zerzri Y; Kallel-Sellami M; Abdelmalek R; Laadhar L; Ben Chaabane T; Makni S
Tunis Med; 2010 Apr; 88(4):269-76. PubMed ID: 20446263
[TBL] [Abstract][Full Text] [Related]
2. [Complement protein hereditary deficits during purulent meningitis: study of 61 adult Tunisian patients].
Kallel-Sellami M; Abdelmalek R; Zerzeri Y; Laadhar L; Blouin J; Zitouni M; Bacchi VF; Ben Chaabene T; Makni S
Arch Inst Pasteur Tunis; 2006; 83(1-4):25-34. PubMed ID: 19388594
[TBL] [Abstract][Full Text] [Related]
3. Hereditary deficiency of the fifth component of complement in man. I. Clinical, immunochemical, and family studies.
Rosenfeld SI; Kelly ME; Leddy JP
J Clin Invest; 1976 Jun; 57(6):1626-34. PubMed ID: 932197
[TBL] [Abstract][Full Text] [Related]
4. [Recurring meningococcal meningitis in hereditary C 5 deficiency].
Hildenhagen O; Bitter-Suermann D
Dtsch Med Wochenschr; 1985 Sep; 110(39):1498-501. PubMed ID: 3928316
[TBL] [Abstract][Full Text] [Related]
5. Hereditary deficiency of the fifth component of complement in man. II. Biological properties of C5-deficient human serum.
Rosenfeld SI; Baum J; Steigbigel RT; Leddy JP
J Clin Invest; 1976 Jun; 57(6):1635-43. PubMed ID: 777027
[TBL] [Abstract][Full Text] [Related]
6. [The association between deficiency of terminal complement components and the occurrence of meningococcal meningitis].
Nishizaki M
Fukuoka Igaku Zasshi; 1992 May; 83(5):201-8. PubMed ID: 1612549
[TBL] [Abstract][Full Text] [Related]
7. [2 families with meningococcal infection and a hereditary disorder of the 5th component of the complement system].
Fijen CA; Kuijper EJ; Lindeboom SF; van Os J; van Putten JP
Ned Tijdschr Geneeskd; 1989 Sep; 133(36):1796-800. PubMed ID: 2682274
[TBL] [Abstract][Full Text] [Related]
8. Studies on the mechanism of bacterial resistance to complement-mediated killing. VI. IgG increases the bactericidal efficiency of C5b-9 for E. coli 0111B4 by acting at a step before C5 cleavage.
Joiner KA; Goldman RC; Hammer CH; Leive L; Frank MM
J Immunol; 1983 Nov; 131(5):2570-5. PubMed ID: 6355297
[TBL] [Abstract][Full Text] [Related]
9. Combined complete C5 and partial C4 deficiency in humans: clinical consequences and complement-mediated functions in vitro.
Gianella-Borradori A; Borradori L; Schneider PM; Gautier E; Späth PJ
Clin Immunol Immunopathol; 1990 Apr; 55(1):41-55. PubMed ID: 2306879
[TBL] [Abstract][Full Text] [Related]
10. Hereditary C5 deficiency in man. III. Studies of hemostasis and platelet responses to zymosan.
Breckenridge RT; Rosenfeld SI; Graff KS; Leddy JP
J Immunol; 1977 Jan; 118(1):12-6. PubMed ID: 830743
[TBL] [Abstract][Full Text] [Related]
11. Recurrent bacterial meningitis in patients with genetic defects of terminal complement components.
Haeney MR; Thompson RA; Faulkner J; Mackintosh P; Ball AP
Clin Exp Immunol; 1980 Apr; 40(1):16-24. PubMed ID: 7389212
[TBL] [Abstract][Full Text] [Related]
12. Recurrent meningitis in a patient with congenital deficiency of the C9 component of complement. First case of C9 deficiency in Europe.
Zoppi M; Weiss M; Nydegger UE; Hess T; Späth PJ
Arch Intern Med; 1990 Nov; 150(11):2395-9. PubMed ID: 2241452
[TBL] [Abstract][Full Text] [Related]
13. [Hereditary complement deficiencies].
Fischer E
Hautarzt; 1982 Feb; 33(2):65-72. PubMed ID: 6281215
[TBL] [Abstract][Full Text] [Related]
14. A complement C5 gene mutation, c.754G>A:p.A252T, is common in the Western Cape, South Africa and found to be homozygous in seven percent of Black African meningococcal disease cases.
Owen EP; Würzner R; Leisegang F; Rizkallah P; Whitelaw A; Simpson J; Thomas AD; Harris CL; Giles JL; Hellerud BC; Mollnes TE; Morgan BP; Potter PC; Orren A
Mol Immunol; 2015 Mar; 64(1):170-6. PubMed ID: 25534848
[TBL] [Abstract][Full Text] [Related]
15. Recurrent meningococcal sepsis in a presumptive immunocompetent host shown to be complement C5 deficient-a case report.
Grimnes G; Beckman H; Lappegård KT; Mollnes TE; Skogen V
APMIS; 2011 Jul; 119(7):479-84. PubMed ID: 21635555
[TBL] [Abstract][Full Text] [Related]
16. The activation of C5 in the fluid phase and in the absence of C3 through the classical pathway of the complement system.
Kitamura H; Tsuboi M; Nagaki K
Immunology; 1986 Jul; 58(3):459-65. PubMed ID: 3733147
[TBL] [Abstract][Full Text] [Related]
17. [Meningococcal meningitis in isolated familial deficiency of the 7th complement component, C7].
Straub PW; Späth P
Schweiz Med Wochenschr; 1986 May; 116(21):699-702. PubMed ID: 3726502
[TBL] [Abstract][Full Text] [Related]
18. Complement C7 deficiency presenting as recurrent aseptic meningitis.
Corvini M; Randolph C; Aronin SI
Ann Allergy Asthma Immunol; 2004 Aug; 93(2):200-5. PubMed ID: 15328683
[TBL] [Abstract][Full Text] [Related]
19. C3 metabolism in a patient with deficiency of the second component of complement (C2) and discoid lupus erythematosus.
Wild JH; Zvaifler NJ; Müller-Eberhard HJ; Wilson CB
Clin Exp Immunol; 1976 May; 24(2):238-48. PubMed ID: 1084239
[TBL] [Abstract][Full Text] [Related]
20. Which complement assays and typings are necessary for the diagnosis of complement deficiency in patients with lupus erythematosus? A study of 25 patients.
Boeckler P; Meyer A; Uring-Lambert B; Goetz J; Cribier B; Hauptmann G; Lipsker D
Clin Immunol; 2006 Nov; 121(2):198-202. PubMed ID: 16987709
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]